Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. Implant Science's QS-H150 Portable Explosives Detectors has been Designated as Qualified Anti-Terrorism Technology by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products.

Founded in 1993 by Andrew Cousin, Amersham Corp. is a private equity firm located in Louisville, Colorado with additional offices in California, Florida, Texas and China.

Roussel UCLAF.

Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA.

IDS is a global medical diagnostics business dedicated to the development and provision of innovative automated and manual assays. Our development focus is in the clinical areas of bone and calcium metabolism, growth, hypertension and chronic kidney disease. Our IDS-iSYS system is designed with the flexibility to accommodate unique and challenging requirements, the IDS-iSYS automation brings testing efficiency and uncompromised quality to specialty immunoassay testing. IDS provides a compact bench top system that fully automates immunoassay testing.

BioSurface Engineering Technologies, Inc., also known as BioSET, engages in developing proprietary therapeutic peptides as medical devices to improve bone and soft tissue repair. The company focuses on developing devices for orthobiologics applications. Its products include AMPLEX, an implantable combination device of the B2A peptide and a synthetic ceramic scaffold for use as a surgical bone graft implant for lumbar degenerative disc disease, as well as for use in spine, cervical spine, and foot and ankle fusion surgeries. The company also develops products for sports medicine applications based on its F2A peptide; and peptide signaling molecules and various scaffold biomaterials for use in musculoskeletal applications, including trauma, fracture repair, and other soft tissue treatments. BioSurface Engineering Technologies, Inc. was founded in 2001 and is based in Rockville, Maryland.

Sun Rainforest (Xiamen) Biopharmaceutical Co., Ltd., established on 2015-09-06, Business scope includes engineering and technology research and experimental development;Medical Research and Experimental Development;Biopharmaceutical Manufacturing;Natural science research and experimental development;Cosmetic Manufacturing;Sanitary materials and medical supplies manufacturing;Manufacturing of chemical preparations;second,Retailing of Class III Medical Devices;Western medicine retail;Hazardous Chemical Retail;Manufacturing of other daily chemical products(Items not subject to permit approval);Manufacturing of other basic chemical raw materials(Free of hazardous chemicals, monitored chemicals and non-pharmaceutical precursor chemicals);Manufacturing of organic chemical raw materials(Free of hazardous chemicals, monitored chemicals and non-pharmaceutical precursor chemicals);Manufacturing of chemical raw materials(Free of hazardous chemicals, monitored chemicals and non-pharmaceutical precursor chemicals);Technology intermediary service;Biotechnology Extension Services;New material technology promotion service;Other technical promotion services;Other unspecified technology promotion and application service industries;Glue Manufacturing;Manufacture of other specialty chemical products(Free of hazardous chemicals, monitored chemicals and non-pharmaceutical precursor chemicals);Biomass material manufacturing;Manufacture of High Performance Membrane Materials;Eco-environmental material manufacturing;Manufacture of other unlisted synthetic materials;Retailing of Class I Medical Devices;Retailing of cosmetics and hygiene products;Other unspecified retail trade(Items not subject to permit approval).

Chengdu Yunke Pharmaceutical Co., a subsidiary of Yantai Dongcheng Biochemicals Co., Ltd., is a Chinese company located in Chengdu that engages in biotechnology development operation. On April 21, 2015 Yantai Dongcheng Biochemicals Co., Ltd. acquired Chengdu Yunke Pharmaceutical Co. for $170.69 million.

Xuzhou Central Hospital is a Chinese private company located in Xuzhou. The firm owns and operates general medical and surgical hospitals.

Ningbo Junan Pharmaceuticals Technology Co. Ltd. produces and distributes Iodine-125 sealed sources and Strontium-89 chloride injections. The company is headquartered in Ningbo, China.

Tianjin Saide Biopharmaceutical Co., Ltd., established on 2004-05-28, Business scope includes in vivo radiopharmaceutical production,operate;Production of antibodies and reagents for scientific research,operate(Only for scientific research and not for clinical diagnosis);biomedicine,medical instruments,digital information,Technology development of mechatronics technology and products,consult,Serve,transfer;chemical industry(Dangerous goods except precursor drugs),Wholesale and retail of instruments and meters;Import and export,Technology Import and Export(Except for laws and regulations restricting import and export).(If the above business scope involves industry licensing, the license certificate,Operate within the validity period,If the country has special franchise regulations, it shall be handled in accordance with the regulations)

Manufactures pharmaceutical preparations

National Institutes for Quantum and Radiological Science and Technology is a national research and development corporation.

Ferring BV offers pharmaceutical products. It offers medicines in Gynaecology, Gastroenterology, Endocrinology and Urology. The company was founded in 1984 and is headquartered in Hoofddorp, Netherlands.

G.D. Searle, LLC is a wholly owned trademark of Pfizer. It is currently used mainly as a distribution trademark for various pharmaceuticals that were developed by G. D. Searle & Company (often referred to as Searle). Prior to its 1985 merger with Monsanto, Searle was a company focusing on life sciences, specifically pharmaceuticals, agriculture, and animal health.

Draximage, Inc. operates as pharmaceutical company. It focuses on nuclear medicine. The firm offers lyophilized kits and radiotherapy products based on iodine. The company is headquartered in Kirkland, Canada.

The Korea Atomic Energy Research Institute (KAERI) in Daejeon, South Korea was established in 1959 as the sole professional research-oriented institute for nuclear power in South Korea, and has rapidly built a reputation for research and development in various fields. In 1995 KAERI designed and constructed the nation's first multipurpose research reactor, HANARO based on the Canadian MAPLE design. KAERI is dedicated to finding a wide range of uses for atomic energy. As examples, KAERI developed the world's first radiopharmaceutical "Milican injection" for treating liver cancer.